Inhibition of mitochondrial complex II affects dopamine metabolism and decreases its uptake into striatal synaptosomes

Folia Neuropathologica

Volumn 44, Issue 4, 2006, Pages 238-243

  Cakała, Magdalena ^a   Drabik, Jacek ^a   Kaźmierczak, Anna ^a   Kopczuk, Dorota ^a   Adamczyk, Agata ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

3 nitropropionic acid; DAT; Dopamine; Nitric oxide; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; MITOCHONDRIAL COMPLEX II; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDOREDUCTASE; SCAVENGER; SUCCINATE DEHYDROGENASE; TEMPOL; TRITIUM; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOWN REGULATION; DRUG ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIPID PEROXIDATION; METABOLITE; NONHUMAN; OXIDATIVE STRESS; RAT; SPECTROPHOTOMETRY; SYNAPTOSOME;

EID: 33846174296     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adamczyk A, Kazmierczak A, Strosznajder JB. Alpha-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide. Neurochem Int 2006; 49: 407-412.
2. Asakawa T, Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid peroxides. Lipids 1980; 15: 137-140.
3. Blum D, Galas MC, Cuvelier L, Schiffmann SN. Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability. Neurosci Lett 2004; 354: 234-238.
4. Bowyer JF, Clausing P, Schmued L, Davies DL, Binienda Z, Newport GD, Scallet AC, Slikker W Jr. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum. Brain Res 1996; 712: 221-229.
5. Fernagut PO, Diguet E, Jaber M, Bioulac B, Tison F. Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. Eur J Neurosci 2002; 15: 2053-6.
6. Fu Y, He F, Zhang S, Huang J, Zhang J, Jiao X. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum. Neurotoxicol Teratol 1995; 17: 333-339.
7. Hamilton BF, Gould DH. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 1987; 72: 286-297.
8. Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S, Sanmartin-Suarez C, Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 2004; 45: 103-116.
9. Johnson JR, Robinson BL, Ali SF, Binienda Z. Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats. Toxicol Lett 2000; 116: 113-118.
10. Li CL, Werner P, Cohen G. Lipid peroxidation in brain: interactions of L-DOPA/dopamine with ascorbate and iron. Neurodegeneration 1995; 4: 147-153.
11. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin fenol reagent. J Biol Chem 1951; 193: 265-275.
12. Maragos WF, Jakel RJ, Pang Z, Geddes JW. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Exp Neurol 1998; 154: 637-644.
13. Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. Biochem Pharmacol 2002; 63: 1499-1505.
14. McLaughlin BA, Nelson D, Erecinska M, Chesselet MF. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 1998; 70: 2406-2415.
15. Nishino H, Kumazaki M, Fukuda A, Fujimoto I, Shimano Y, Hida H, Sakurai T, Deshpande SB, Shimizu H, Morikawa S, Inubushi T. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci Res 1997; 27: 343-355.
16. Reynolds DS, Carter RJ, Morton AJ. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 1998; 18: 10116-10127.
17. Richter HW, Waddell WH. Mechanism of the oxidation of dopamine by the hydroxyl radical in aqueous solution. J Am Chem Soc 1983; 105: 5434-5440.
18. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995; 15: 8419-8429,
19. Slivka A, Cohen G. Hydroxyl radical attack on dopamine. J Biol Chem 1985; 260: 15466-15472.
20. Spencer JP, Jenner A, Butler J, Aruoma OI, Dexter DT, Jenner P, Halliwell B. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease. Free Radic Res 1996; 24: 95-105.
21. Sulkowski G, Dabrowska-Bouta B, Waskiewicz J, Rafalowska U. Inhibition of dopamine transport and binding of [3H] spiperone to dopamine D2 receptor by acute Pb-toxicity in vivo. Folia Neuropathol 1999; 37: 205-209.
22. Yen GC, Hsieh CL. Antioxidant effects of dopamine and related compounds. Biosci Biotechnol Biochem 1997; 61: 1646-1649.
23. Zeevalk GD, Derr-Yellin E, Nicklas WJ. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J Neurochem 1995; 64: 455-458.